The increased abuse of opioids -such as oxycodone -poses major challenges for health and socioeconomic systems. Here we present a novel oral oxycodone self-administration paradigm in rats that recapitulates key aspects of prescription opioid abuse: voluntary drug intake, long-term opioid exposure, measurable levels of dependence, and increased motivation to take drug. Adult female and male Long-Evans rats were given unlimited, home cage access to two bottles containing water (Control rats) or one bottle of water and one bottle of Oxycodone dissolved in water (Experimental rats). Virtually all Experimental rats voluntarily drank oxycodone (~10 mg/kg/day) and escalated their intake over 22 weeks.
INTRODUCTION
Opioid misuse and abuse have reached epidemic status worldwide, posing major challenges for health and socioeconomic systems [1] [2] [3] . Opioids such as oxycodone are mainstays of pain management [4, 5] , but the relatively easy access to these medications and their common diversion has led to higher incidence of addiction in the exposed population [3, 6, 7] . This increase has deadly consequences; in 2014, oxycodone ranked third behind heroin and cocaine in causing overdose deaths [8] . As initial use of opioids can result in dependence that leads to concomitant or replacement use of more accessible, less expensive but more lethal opioids, i.e. heroin or fentanyl, it is critical to understand the factors underlying prescription opioid abuse liability [6] .
To understand these factors, preclinical researchers need an animal model of prescription opioid abuse liability that recapitulates key aspects of long-term use -dependence, tolerance, and reinforcement [9] [10] [11] . Prescribed oxycodone is typically taken orally, and animal models of oral opioid self-administration have been in use for many years [12] [13] [14] [15] [16] [17] [18] [19] ; but these models have caveats. In oral models often animals are forced to "self-administer" (drink) an opioid solution by provision of only drugged water, or are provided a drug solution adulterated with an alternative reinforcer, such as sucrose [20] . The high blood levels of drug achieved in oral administration models require concentrated drug solutions that may be aversive to drink. If diluted to increase palatability, the dosing of the opioid is limited [20] . At present, there are no preclinical oral models that offer an animal continuous choice (24 hours/day [h/d], 7 d/week
[wk]) between natural rewards (food/water) and oral, unadulterated oxycodone. Such a model would provide a translationally-relevant tool to test interventions and to interrogate variables such as sex differences [21] [22] [23] [24] and the gut microbiome [25] that are challenging to study in existing opioid self-administration models. Improved oral opioid abuse models would also complement IV self-administration models by enabling the study of transition between stages of addiction, thereby facilitating intervention testing.
Here we describe a novel rat model, termed PoVOCC (Per os Volitional Oxycodone Continuous Choice), that provides rats with prolonged, unlimited access to oxycodone and leads to escalation, dependence, and marked motivation to ingest the drug. We show PoVoCC recapitulates many features of human oxycodone abuse in female and male rats.
We believe PoVOCC will be useful for probing neural and physiological mechanisms that mediate long-term voluntary drug use and exploration of potential treatment options.
METHODS

Animals and husbandry.
Animal procedures were in accordance with federal guidelines [26] and the Institutional Animal Care and Use Committee (IACUC) at the Children's Hospital of Philadelphia Research Institute (CHOP), and were performed in AAALAC-approved facilities at CHOP (AAALAC Unit # 000427, PHS Animal Welfare Assurance #D16-00280 [A3442-01]).
Efforts were made to minimize both animal distress and the number of animals used. Female (n=12) and male (n=12) Long-Evans Hooded rats (Envigo, 60-65 day-old) were individuallyhoused in a vivarium (temperature, 20-23°C; humidity 30-70%: lights on/off: 6:15AM/6:15PM). Food and water were provided ad libitum throughout the experiment.
(Additional details in Supplementary Methods.) Baseline behavioral assessment. After at least two weeks of individual housing, rats were tested in the open field and for marble burying behavior ( Fig. 1) . Open field was performed as previously described [27, 28] with minor modifications. One day later, rats were then assessed for marble burying, as previously described [29] [30] [31] [32] [33] with minor modifications. (Additional details in Supplementary Methods.)
Oxycodone self-administration. After behavioral assessment ( Fig. 1 During Baseline (Weeks -1 and 0, Fig. 1 adapted from previous studies [35] [36] [37] [38] [39] .
Serum assessment of oxycodone levels. Blood was taken via tail vein under isoflurane
anesthesia and assessed for oxycodone levels according to prior protocols [40, 41] .
(Additional details in Supplementary Methods.)
Gnawing home cage behavior. At Week 12, each rat cage received 1 nylabone and 1 wood gnawing block (Bio-Serv K3512 medium size). The weight of both the nylabone and block were recorded daily at the same time. The change in weight of each item was calculated to derive a gnawing index, defined as the total amount in grams of nylabone and wood block chewed over time.
Citric acid aversion test. The citric acid (CA) aversion test was guided by prior work [42] [43] [44] [45] with significant modifications. Between Week 27 and 29 all rats received ascending concentrations of citric acid (CA, Sigma Aldrich, cat# PHR1071) at 1, 3, and 5mM in the back bottle. The 5mM CA was repeated (5 and 5') . In between each CA exposure, rats received their original bottle (water or oxycodone) for 2 days to allow for return to baseline. Liquid intake, body weight, preference, and deviation from baseline were scored daily.
Precipitated withdrawal. On
Week 31 all rats were tested for signs of withdrawal Table) based on prior work [38, 39, [46] [47] [48] [49] [50] 
(Supplementary
RESULTS
Pre-screening for a predictive endophenotype: assessment prior to experimental assignment revealed no overt group differences.
Pre-screening behavioral assessment. Prior to any manipulation, all rats were pre-screened for open field (OF1) behavior, as an indicator of both anxiety and locomotor activity [56, 57] and marble burying, as repetitive behavior [58] often associated with anxiety-like phenotypes [59] . For OF1 the total distance travelled ( Fig. 1B) and number of entries into the center zone ( Fig. 1C) were similar within groups irrespective of Sex or the to-be-assigned Treatment (Control or Experimental). There was a significant main effect of Sex of duration in the Intermediate zone ( Fig. 1D) , with females spending ~3x more time in Intermediate zone than males. We found no difference in number of marbles buried driven by Sex or to-be-assigned Treatment group (Fig. 1E) . Thereby at pre-screening the behavior parameters were similar, with the exception that females showed higher levels of novelty-seeking (longer time spent in the Intermediate zone in the OF1 relative to males).
Baseline Water/Water intake. At baseline (average of Week -1 and Week 0, Fig. 1A ), Control and Experimental rats received two bottles of water in their home cage ( Fig. 1F) . There was no effect of Treatment or Sex in the average amount of liquid (water) ingested during Baseline ( Fig. 1G) . There was no effect of Treatment and Sex in the preference for the front or the back bottle ( Fig. 1H) . Within Sex, rats had similar body weights ( Fig. 1I) , with females as expected weighing less than males. Thus, the random assignment to either Control or Experimental group was unbiased.
Experimental rats increased their oxycodone preference and drank more oxycodone over time, with females ingesting more than males and having higher oxycodone blood levels.
During the 2-bottle-choice period (see Fig. 1A ), female Experimental rats increased their total liquid intake from Week 19 compared to Week 1, whereas male Experimental rats did not ( Fig. 2A) . Both females and males increased their preference for oxycodone by Week 9
relative to Week 1. When the bottle position was switched, both females and males maintained their preference for oxycodone, but male rats increased their preference for the oxycodone by Week 17 compared to the week prior to bottle switch (Week 11; Fig. 2B ).
Furthermore, female and male rats self-administered a higher dose of oxycodone over time, with females self-administering a higher dose by Week 9, whereas males self-administered a higher dose by Week 14 (Fig. 2C) . Females self-administered higher doses than males on Weeks 9 to 12, 17, 18 and 20 to 22. The greater oxycodone intake in females was reflected in higher oxycodone blood levels compared to males ( Fig. 2D) . When dose of oxycodone was correlated with blood levels, the relationship was significant and positive for males, but not significant for females ( Fig. 2E ).
Experimental rats show higher levels of dependency in precipitated withdrawal and increased gnawing behavior.
Withdrawal in home cage. Daily assessment of home cage spontaneous withdrawal symptoms showed no significant difference between groups when analyzed as individual behavior or when the total sum of these behaviors was collapsed over 22 weeks (Fig. 3A) .
Overall, Experimental rats chewed more nylabone and wooden block in the home cage between Weeks 12 and 22 of oxycodone exposure than did Control rats, whereas
Experimental females gnawed more than Control females, Control males, and Experimental males, Experimental males did not differ from Control males ( Fig. 3B) .
Precipitated withdrawal. In contrast to home cage withdrawal behaviors, Experimental rats presented more precipitated withdrawal symptoms than Control rats at Week 31 for key behaviors analyzed separately: burrow, teeth chatter, high walk, and diarrhea. When total precipitated withdrawal score was analyzed, Experimental females and males presented more withdrawal signs than respective controls ( Fig. 3C) . After precipitated withdrawal, Experimental females lost four-fold more weight than Control females, and Experimental males lost two-fold more than Control males ( Fig. 3D ).
Ascendant concentrations of CA suppressed intake in both Control and Experimental rats, but Experimental rats returned to initial baseline preferences whereas Control rats did not.
When provided ascending concentrations of CA in the back bottle ( Fig. 4A) , all rats suppressed their preference; Experimental males suppressed at 3mM CA whereas the other groups suppressed at 5mM ( Fig. 4B) . When CA was removed during the interspersed baselines, Experimental rats returned to the initial baseline preference, whereas Control rats maintained their aversion ( Fig. 4C) .
Pre-screening of open field behavior predicted oxycodone intake-related outcomes in both female and male rats.
For an unsupervised picture of the relationship between open field behavior and dependent measures during oxycodone intake (precipitated withdrawal, spontaneous withdrawal, intake, preference, CA, blood, gnawing, etc.), we conducted a factor analysis of all pre-screened open field behaviors. Analysis revealed a single factor from pre-screening open field explained ~71% of the variance each for females ( Supplementary Fig. 1A ) and males ( Supplementary Fig. 1B) . To obtain a single score for each rat, the pre-screening open field behavior measures were multiplied by the factor score of that behavior and summed. Each rat's factor score was then correlated with the dependent measures during the oxycodone intake phase. For females, only gnawing was significantly correlated with the open field measure. For males, significant correlations were seen with precipitated withdrawal weight loss, gnawing, oxycodone dose at Week 22, liquid intake at Week 22, and blood levels ( Supplementary Fig. 1C ). Fig. 1D ) revealed a positive relationship between oxycodone intake in female and male rats in Week 22 and prescreening activity in activity measurements and Center areas of the open field. In both female and males rats we did not observe significant correlations in the post-screening activity.
Graphic representation of the correlation data (Supplementary
Chronic oral oxycodone decreases alpha-diversity but has a mild impact on gut microbiome composition.
In both Control and Experimental rats, Bacteroides and Firmicutes dominated the gut microbial composition whereas Actinobacteri, Cyanobacteria, Deferribacteres, Lentisphaerae, Proteobacteria, Tenericutes, Verrucomicrobia were present in low abundance (Fig. 5A) .
Analysis of relative abundance at the Phylum level at Week 28 showed several bacterial Phyla varied between Control and Experimental rats ( Fig. 5B ; remainder of ranks,
Supplementary Tables 2-5). Alpha diversity at
Week -1 vs. Week 28 did not differ in Controls but did in Experimental rats ( Fig. 5C) , with a lower alpha diversity of gut microbial communities seen at Week 28 of Experimental rats. Beta diversity and principal coordinates analysis (PCoA) revealed that rats within treatment groups clustered more closely than those from different treatment groups (Fig. 5D ).
DISCUSSION
Important aspects of a preclinical model for human prescription opioid abuse liability include prolonged and unlimited drug access, voluntary self-administration when a choice is provided, high levels of intake, drug dependence, and subsequent somatic signs of opioid withdrawal. Here we present a novel oxycodone self-administration paradigm in rats, PoVOCC, that recapitulates these key features of human prescription opioid abuse. In the PoVOCC model, rats given continuous choice between oxycodone and water reliably demonstrated voluntary and escalating intake of oxycodone, measurable levels of dependence, and motivation to take the drug. We believe this preclinical model of prescription opioid abuse -which relies on oxycodone oral voluntary self-administration -is of significant translational relevance for understanding the mechanisms that underlie opioid addiction and ultimately will contribute to the ongoing research efforts to combat the growing opioid epidemic.
Conceptual and methodological advantages of PoVOCC
The face validity of opioid self-administration models is based on an animal's motivation to
seek and to take drug [60] and to do so despite adverse consequences [61] . In the PoVOCC model, rats readily drank oxycodone, and showed a preference for the oxycodone-containing bottle relative to the water bottle. Experimental rats escalated their oral oxycodone intake over time, suggesting it was reinforcing, and rebounded to these high levels of intake following citric acid suppression. Thus, rats in the PoVOCC model show motivation to drink in the face of adverse consequences.
In contrast to our PoVOCC model, other opioid self-administration paradigms rely either on oral intermittent access (OIA) or intravenous (IV) self-administration [16, 20, 35, [62] [63] [64] [65] [66] [67] [68] [69] [70] . Both OIA and IV self-administration models lead to dependence and tolerance, and IV models demonstrate drug-seeking motivation. OIA models mimic a common route of administration of humans (oral), whereas the rapid onset of IV drug effects enables assessment of contingent cues and behaviors. However, these models have limitations. High first-pass metabolism of drug in OIA opioid models results in a short bioavailability and longer latencies to induce the "high" compared to IV models [40] . IV self-administration models often rely on short-term access, which confounds assessment of drug effects vs. those caused by daily withdrawal [9, 20, 71] . We believe the PoVOCC model addresses some of these issues. Its advantages include: a) the translational relevance for orally-delivered drugs, b) voluntary intake and choice between natural rewards (food/water) and oxycodone, c) the chronicity of drug available 24h/7d over months, d) the non-invasive methodological approach, and e) the absence of confounders, such as adulteration of oxycodone solution to encourage oral intake or stress the animal to induce intake.
PoVOCC models sex differences in oxycodone intake and blood levels
Prescription opioid abuse liability is likely sex-dependent [72, 73] . There is a more rapid increase in the rate of prescription opioid abuse in women than men [8] . Sex hormones appear to play a role in opioid dependence and reinforcement [48, 72, [74] [75] [76] [77] [78] [79] , including in oral self-administration protocols [80] . Sex differences are also apparent in the pharmacokinetic, metabolic, and analgesic effects of oxycodone [40, 81, 82] , and in the liability for opioid abuse [83, 84] . In preclinical studies, females self-administer more opioids, are more vulnerable to their reinforcing effects, and become more physically-dependent than males [23, 24, 36, 75, [77] [78] [79] [85] [86] [87] . In our PoVOCC model, both sexes readily drank oxycodone but females selfadministered two-fold more oxycodone than males, with resultant five-fold higher blood levels. Female rat preference for oxycodone peaked early and remained high, whereas male rat preference peaked later; these differences were independent of oxycodone concentrations. Female individual differences during pre-screening were less predictive of intake, self-administered dose, blood levels, and gnawing behavior than male individual differences. Thus, the PoVOCC model appears suited to interrogate sex differences under a choice oxycodone self-administration paradigm.
Although we did not investigate sex differences in pharmacokinetics, the large difference in dosing we observed could have been driven by sex differences in oxycodone metabolism that are reported in humans [85, 88] and in some, but not all, studies in Sprague Dawley rats [40, 83] . In our PoVOCC model with Long Evans rats, one reasonable -but as yet untestedexplanation for the higher total liquid intake in females is their attempt to keep oxycodone blood levels constant. This would argue in favor of a faster elimination rate (but see [40] ), lower oxycodone sensitivity and/or different first pass metabolism, resulting in greater intake at the same concentration compared to males. Further studies on blood sampling at earlier and multiple time points, with measures of metabolites, are warranted to test this hypothesis.
PoVOCC as a model of dependence and stereotyped gnawing behavior
In contrast to short-term access paradigms [9, 20, 71] [90] [91] [92] . One source of stress in our PoVOCC model is social isolation, as rats were singlyhoused for 10 months. However, isolation is unlikely the sole contributor to increased gnawing behavior as no control rats measurably gnawed. It is possible that the combination of oxycodone and isolation increased the likelihood of gnawing, and we might expect that group-housed oxycodone rats would gnaw less than isolated oxycodone rats. Moreover, because social isolation is more stressful for females than males [93] [94] [95] , the increased gnawing in particular by experimental females may be explained by an opioid-mediated activation of the dopaminergic mesolimbic system known to induce gnawing behavior [90, 91] .
PoVOCC model: appetitive and reinforcing behavior, escalation, and incentive salience
In addition, when challenged to drink an aversive tastant added to the oxycodone bottle, most 
Changes in the gut microbiome in the PoVOCC model
Humans and animals exposed to opiates -typically morphine is studied -have altered gut microbiome [25, [96] [97] [98] [99] [100] [101] . In general, these opioid-induced alterations manifest in a switch from gram-negative to gram-positive bacteria, where the latter dominates the gut composition. The functional importance of a switch in bacteria or in levels of alpha-diversity remains a hotly-debated issue [102] . However, the opioid-induced switch in bacteria has been postulated to contribute to gut permeability, sustained systemic inflammation, and even opioid tolerance [96, 98, 103] , with duration of morphine exposure appearing to be a key driver of gut microbiome [97] . In contrast to work on experimenter-delivered morphine, little is know about how oxycodone or any other self-administered opioid influences the gut microbiome in 
Pre-screening for predictive factors
Not all humans become addicted to drugs, and those that do show different degrees of dependence [7, 104] . The individual differences that emerge during the PoVOCC model can be harnessed to identify individual vulnerabilities that may be predictive of oxycodone abuse liability. Locomotion, exploratory activity, and anxiety-like phenotypes can be predictive of later drug-seeking behavior [11, 105] . In our present work, there were sex differences in the prescreening prediction of later intake and intake-related variables; pre-screened open field behaviors predicted intake and intake-related variables and some components of dependence in males but not females. A caveat of this is that females had consistently higher levels of oxycodone intake than males. Thus, the fewer predicted intake specific variables for females compared to males may reflect a ceiling effect specifically for intake variables. This ceiling effect is less likely to explain the lack of correlation for non-intake-related variables such as weight loss after precipitated withdrawal.
Conclusions
PoVOCC is a model of voluntary, continuous access, oral oxycodone intake in rats. It mimics oral ingestion of oxycodone in humans, allowing the animal to titrate its own oxycodone levels and the development of physical dependence in a sex-dependent manner. Experimental rats show motivation to drink oxycodone. Future work would address why and how individual rats differ in their intake, pre-existing risk factors that might predict high levels of intake, mechanisms underlying the sex differences, and the gut microbiome alterations found in these studies. The PoVOOC model will be useful for probing treatment options, pharmacological and environmental, and in particular the role of stress and isolation in the motivation to take opioids. Post-hoc analysis within same sex group showed that female rats self-administered oxycodone at a higher dose from Week 9 on compared to Week 1 (a: Week 1 vs 10 p=0.0002, Week 1 vs 12 p=0.0030, Week 1 vs 13 p=0.0002, Week 1 vs 13 p=0.0001 (D) Analysis via two-tailed unpaired t-test of oxycodone blood levels between female and male rats averaged over the two blood draws at Weeks 15 and 21 revealed a significant difference between sexes (***p=0.0003).
FUNDING AND DISCLOSURE
(E) Correlation analysis of the blood levels with the intake 12 hours prior blood collection revealed a significant positive correlation in males with the slope of the linear regression of 0.8874, r 2 =0.5738, and p=0.0181, whereas for females the slope of the linear regression was -4.458, r 2 =0.1965, and p=0.2320. revealed no interaction and no effect of Treatment or Sex for frequently occurring behaviors: Post-hoc analysis between treatment groups showed a higher total withdrawal score in experimental females and males compared to their respective same sex controls (**p=0.0041 and *p=0.0139, respectively). Post-hoc analysis showed that Control female and male rats maintained their aversion (a:
(D)
Control females BL5, *p=0.0151; BL5' **p=0.0046; b: Control males BL5',**** p<0.0001). (C) Kruskall-Wallis analyses comparing alpha diversity among Week -1 vs. Week 28 in Control and Oxycodone rats showed a significant difference (****p=0.0001743). Post-hoc analysis showed that alpha diversity was similar between Week -1 Control and Week -1
Oxycodone (p=0.6631), Week -1 Control and Week 28 Control (p=0.5569), Week -1
Oxycodone and Week 28 Control (p=0.9192) and differed between Week -1 Control and
Week 28 Oxycodone (p=0.0026), Week 28 Control and Week 28 Oxycodone (p=0.0563) and
Week -1 Oxycodone and Week 28 Oxycodone (p=0.0005).
(D) Bray Curtis Dissimilarity and principal coordinates analysis (PCoA) revealed gut microbial composition are more similar within treatment groups than between treatment groups (PERMANOVA R^2 = 0.19098; p = 2e-04 ***).
